Multiple Chemical Sensitivities: A Practicing Clinician's Point of View Clinical and Immunologic Research Findings

Aloia J.F. , Vaswani A. , Ross P. , and Cohn S.H. (1990). Aging bone loss from the femur, spine, radius, and total skeleton. Metab. Clin. Exp. (USA) 39(11):1144–1150.

Bennett J.E. (1990). Searching for the yeast connection. N. Engl. J. Med. 323(25):1766.

Buckley R.H. and Schiff R.I. Drug therapy: The use of intravenous gammaglobulin in immunodeficiency diseases. (1991) N. Eng. J. Med. 325(2):110–117.

Bussel J.B. (1989). The use of intravenous gamma-globulin in idiopathic thrombocytopenic purpura. In: Autoimmunity and Immunointervention. ( Gelfand E.W. , Ochs H.D. , and Stiehm E.R. , eds.), 53(2):S147–S155.

Carey J.T. , Lederman M.M. , and Toossi Z. (1987). Augmentation of skin test reactivity and lymphocyte blastogenesis in patients with AIDS treated with transfer factor. J.A.M.A. 257(15):651–655.

Cohn J.E. , Strong L.E. , Hughes W.L. Jr. , Mulford D.J. , Ashworth J.N. , Melin M. , and Taylor H.L. (1946). Preparation and properties of serum and plasma proteins IV. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids. J. Am. Chem. Soc. 68:459–475.

Dismukes W.E. , Wade J.S. , Lee J.Y. , Dockery B.K. , and Hain J.D. (1990). A randomized, double-blind trial of nystatin therapy for the Candidiasis hypersensitivity syndrome. N. Engl. J. Med. 323(25):1717–1722.

Fernandes P.M. and Lundblad J.L. (1980). Preparation of a stable intravenous gammaglobulin: Process design and scale-up. Vox Sang. 39:101–112.

Fiore M.C. , Anderson H.A. , Hong R.A. (1986). Chronic exposure to aldicarb-contaminated groundwater and human immune function. Environ. Res. 41:633–645.

Gallagher J.C. Kable W.T. , and Goldgar D. (1991). Effect of progestin therapy on cortical and trabecular bone comparison with estrogen. Am. J. Med. 90(2):171–178.

Goldberg R.J. (1983). Psychiatric symptoms in cancer patients. Is the cause organic or psychologic. Postgrad Med 74(1):263–273.

Greico M.H. (1984). Risk of transferring AIDS or hepatitis via immune globulin. J.A.M.A. 24(31):256.

Hofstaetter T. , Gronski P. , Kanzy E.J. , Schorlemmer H.U. , and Seiler F.R. (1983). S-sulfonation: A reversible chemical modification of human immunoglobulins permitting intravenous application. II. Effect on Fc-mediated effector functions. Vox. Sang. 45:155–165.

Kane M.A. (1984). Risk of transferring AIDS or hepatitis via immune globulin. J.A.M.A. 252(8):256.

Kroker G.F. (1987). Chronic candidiasis and allergy. In: Food Allergy and Intolerance. ( Brostoff J. and Challacombe S.J. , eds.). Bailliere Tindall, London, pp. 850–870.

Lawrence H.S. (1955). The transfer in humans of delayed skin sensitivity to streptococcal M substance and to tuberculin with disrupted leucocytes. J. Clin. Invest. 34:219–225.

Levin A.S. (1987). Transfer factor and allergies. In: Food Allergies, ( Brostoff J. , and Challacombe S.J. , eds.). Bailliere Tindall, London, pp.995–1004.

Levin A.S. , Byers V.S. , Fudenberg H.H. , Johnston J.O. , and Wybran J. (1975). Osteogenic sarcoma: Immunologic parameters before and during therapy with tumor specific transfer factor. J. Clin. Invest. 55:487–494

Levin A.S. , Spitler L.E. , Stites D.P. , and Fudenberg H.H. (1970). A genetically determined cellular immunologic deficiency: Clinical and laboratory responses to therapy with transfer factor. Proc. Natl. Acad. Sci. USA 67:821–829.

Levin A.S. and Byers V.S. (1987). Environmental illness: A disorder of immune regulation. Occup. Med.: State Art Rev. 2:(4)669–681.

Lifson J.D. , Finch S.L. , Sasaki D.T. , and Engleman E.G. (1985). Variables affecting T-lymphocyte subsets in a volunteer blood donor population. Clin. Immun. Immunopath. 36:151–160.

Louie E. , Borkowsky W. , and Klesius P.H. (1987). Treatment of cryptosporidiosis with oral bovine transfer factor. Clin. Immunol. Immunopathol. (USA) 44(3):329–334.

Martin M.J. (1983). A brief review of organic diseases masquerading as functional illness. Hosp. Commun. Psych. 34:(4)328–332.

McNEELY S.G. Jr. , Schinefeld J.S. , STOVALL T.G. , LING F.W. , and BUXTON B.H. (1991). Prevention of osteoporosis by medroxyprogesterone acetate in postmenopausal women. Int. J. Gynecol. Obstet. 34(3):253–256

MIRTA C. , WONG M.F. , MOZEN M.M. , MCDOUGAL J.S. , and LEVY J.A. (1986). Elimination of infectious retroviruses during preparation of immunoglobulins. Transfusion 26(4):394–397.

NADER R. , BROWNSTEIN R. , and RICHARD J. (1981). Who's Poisoning America. Sierra Books, San Francisco.

PROSS H.F. , Day J.H. , CLARK R.H. , and LEES R.E.M. (1987). Immunologic studies of subjects with asthma exposed to formaldehyde and urea-formaldehyde foam insulation (UFFI). J. Allergy Clin. Immunol. 79:797–810.

RIPPON J.W. (1982). Medical Mycology, 2nd ed. Saunders W.B., Philadelphia, PA. pp. 507–508.

RODIN A. , MURBY B. , SMITH M.A. , CALEFFI M. , FENTIMAN I. , CHAPMAN M.G. , and FOGELMAN I. (1990). Premenopausal bone loss in the lumbar spine and neck of femur: A study of 225 Caucasian women. Bone (USA) 11(1):1–5.

SATRAN M. , PAUL T.L. , ROTI E. , and BRAVERMAN L.E. (1987). Environmental factors affecting autoimmune thyroid disease. Endocrinol, and Metab. of No. America, pp. 327–338.

GOURIS J.T. (1967). The preparation of plasmin-treated immune serum globulin for intravenous use. Vox. Sang. 13:71–84.

SHARMA M. , MOMTAZ A. , FIROUZ R. , and Ala F. (1979). Transfer factor therapy of human cutaneous leishmania infection (CLI). A double blind clinical trial. In: Immune Regulators In Transfer Factor, ( Kahn A. , Kirkpatrick C.H. , and Hill N.O. , eds.). Academic Press, New York. pp. 563–571.

SHUURMAN H. (1991). Chemicals trophic for thymus and T cells: Risk for immunodeficiency and autoimmunity. Proceedings of 5th International Congress on Immunopharmacy. May 26–31.

SILKWORTH J.B. , ANTRIM L. , and SACK G. (1986). AH receptor mediated suppression of the antibody response in mice is primarily dependent on the AH phenotype of lymphoid tissue. Toxicol. Appl. Pharmacol. 86(3):380–390.

SILKWORTH J.B. and ANTRIM L. (1985). Relationship between AH receptor-mediated polychlorinated biphenyl-induced humoral immunosuppression and thymic atrophy. J. Pharmacol. Exp. Ther. 235(3):606–611.

SOWERS M , CLARK K. , WALLACE R. , JANNAUSCH M. , and LEMKE J. (1991). Prospective study of radial bone mineral density in a geographically defined population of postmenopausal caucasian women. Calcif. Tissue Int. 48(4):232–239.

STEELE R.W. , MYERS M.G. , and VINCENT M.M. (1980). Transfer factor for the prevention of varicella-zoster infection in childhood leukemia. N. Engl. J. Med. 303:355–365.